Edition:
India

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

602.75INR
3:40pm IST
Change (% chg)

Rs-0.90 (-0.15%)
Prev Close
Rs603.65
Open
Rs603.65
Day's High
Rs605.10
Day's Low
Rs600.15
Volume
818,518
Avg. Vol
1,396,057
52-wk High
Rs663.40
52-wk Low
Rs480.20

Summary

Name Age Since Current Position

Yusuf Hamied

2016 Non-Executive Chairman of the Board

Umang Vohra

45 2016 Global Chief Executive Officer, Managing Director, Additional Director

Samina Vaziralli

2016 Executive Vice Chairman of the Board

M. Hamied

2016 Non-Executive Vice Chairman of the Board

Kedar Upadhye

2016 Global Chief Financial Officer

Rajendra Chopra

2017 Compliance Officer, Company Secretary

Adil Zainulbhai

2017 Lead Independent Director

S. Radhakrishnan

2017 Non-Executive Director

Naina Kidwai

60 2015 Independent Director

Punita Lal

2014 Independent Director

Peter Lankau

64 2017 Additional Independent Director

Peter Mugyenyi

2016 Independent Director

Ashok Sinha

2016 Independent Director

Ireena Vittal

2016 Additional Independent Director

Naveen Bansal

2017 IR Contact Officer

Biographies

Name Description

Yusuf Hamied

Dr. Yusuf K. Hamied serves as Non-Executive Chairman of the Board of the Board of Cipla Limited. Dr. Hamied is qualified and eminent chemist. Having obtained a Doctorate in chemistry from Cambridge University, he has done research work under Lord Todd FCS, a Nobel Laureate. He joined the Company at the age of 24 years as an officer-in-charge of research and development in 1960. He was appointed its Managing Director in 1976 and became its Chairman in 1989. He is well-respected for his varied experience of 48 years not only in India but also internationally. Dr. Y.K. Hamied has played the lead role in formulating the Company’s strategy and has also been actively involved in research and development. For his distinguished service and contributions to the pharmaceutical industry, Dr. Y.K. Hamied was awarded the Padma Bhushan, one of the highest civilian awards in India in the year 2005.

Umang Vohra

Mr. Umang Vohra serves as Global Chief Executive Officer, Managing Director, Additional Director of the company. Prior to Cipla, Umang was an Executive Vice President and Head of the North America Generics Business for Dr Reddy's, where he held multiple leadership roles across different functions over 12 years. In the past, Umang has also worked with PepsiCo and Eicher Motors. Umang earned his MBA in General Management from T A Pai Management Institute and his B.E. degree in Computer Science from M. S. Ramaiah Institute of Technology.

Samina Vaziralli

Ms. Samina Vaziralli serves as Executive Vice Chairman of the Board of the Company. She is part of the core leadership team and has been with the company since 2011. Samina graduated from the London School of Economics and Political Science with a MSc. in International Accounting and Finance and was previously with the investment management division of Goldman Sachs. Samina brings diverse experience of working in the United States, the United Kingdom, and more recently India. Samina has played a significant role in the Company’s ongoing transformation journey and has a strong understanding of both operating levers of the business today and key drivers for future growth and sustainability. She has been responsible for successfully incubating and shaping Cipla’s Consumer Healthcare business as part of Cipla New Ventures. She has also recently taken on an expanded role leading global strategic alliances and enabling Cipla’s people strategy and leadership development.

M. Hamied

Mr. M. K. Hamied serves as Non-Executive Vice Chairman of the Board of the Board of Cipla Limited. Mr. Hamied has been working as a Whole-time Director of the Company with effect from 15th December 1983. He was redesignated as Joint Managing Director effective from 6th December 2000. He is a science graduate from Bombay University. Mr. Hamied along with the other Joint Managing Director of the Company is in charge of day-to-day management of the Company with special focus on domestic pharmaceutical markets. He has varied experience in all functions of the Company including production, technical areas, quality management and general administration.

Kedar Upadhye

Mr. Kedar Upadhye serves as Global Chief Financial Officer of the company. Kedar is a qualified Cost Accountant with a follow-on MBA from IIM Bangalore. He brings with him deep experience of the global generics business. Until recently, Kedar was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy’s. Prior to Dr Reddy’s, he has worked with Pepsi India and Thermax Group.

Rajendra Chopra

Mr. Rajendra Chopra serves as Compliance Officer, Company Secretary of the company. Mr. Chopra has rich work experience of over 20 years in the company secretarial and legal functions. He is commerce graduate, law graduate and a member of The Institute of Company Secretaries of India.

Adil Zainulbhai

Mr. Adil Zainulbhai serves as Lead Independent Director of the Company. He was Independent Director of the Cipla Limited., since July 23, 2014. He is currently Senior Advisor to Mckinsey. He retired as Chairman of Mckinsey, India after 34 years at Mckinsey. He graduated in Mechanical Engineering from Indian Institue of Technology. He also has an MBA from Harvard Business School.

S. Radhakrishnan

Mr. S. Radhakrishnan serves as Non-Executive Director of the Company. He is currently serves as Whole-time Director of Cipla Limited., since November 12, 2010. He is a qualified Chartered Accountant, has been with the Company for over 26 years and has experience in financial, commercial, legal and allied areas.

Naina Kidwai

Ms. Naina Lal Kidwai serves as Independent Director of the company. An MBA from Harvard Business School, Ms Kidwai is recognised as an influential player in the banking and financial services industry. Repeatedly ranked in the Fortune global list of Top Women in Business, she has also been on the Wall Street Journal and Financial Times Global List of Women to Watch and was listed by Time Magazine as one of their 15 Global Influentials 2002. She received the Padma Shri Award in 2007 from the Government of India for her contribution to Trade and Industry. Until recently Ms Naina Lal Kidwai was Executive Director on the Board of Hongkong and Shanghai Banking Corporation Limited (HSBC) and was Chairman of HSBC India. She is nonexecutive Director on the Board of Nestle SA and member of the Audit Committee and the Chairman’s and Corporate Governance Committee for Asset Liability Management. She is also a global advisor Harvard Business School and Chairman of its South Asia Advisory Board. A past President of FICCI, Ms Kidwai is the Chairperson of the FICCI Water Mission, FICCI Inclusive Governance Council and the India Sanitation Coalition. Her interests in the environment also include being on the Shakthi Sustainable foundation board and a Global Commissioner for the Climate and Economy.

Punita Lal

Ms. Punita Lal serves as Independent Director of the company. Ms. Lal is a graduate in Economics from St. Stephens College, New Delhi and PGDM from the Indian Institute of Management, Kolkata. She sits on the Board of CEAT Limited as an independent director, is an independent strategy and marketing consultant, and is also affiliated with a global firm as a leadership coach. In her last role, Ms. Punita Lal was the CEO of NourishCo, a JV between PepsiCo and Tatas, where she was responsible for establishing and growing the business, and launching two beverage innovations in the first year of JV operations. An FMCG specialist, Ms. Lal worked in different senior marketing positions with Coca-Cola in China and the Far East until 2002. She then joined PepsiCo as the Head of Marketing for their South Asia business unit, where she was responsible for devising marketing and portfolio strategy across PepsiCo’s beverage brands in South Asia, a USD 1 billion business

Peter Lankau

Mr. Peter Lankau serves as Additional Independent Director of the company. Mr. Lankau has graduated with Bachelors of Science in Biology from the State University of New York at Albany, USA. He has over 30 years of management experience in developing and commercializing pharmaceutical products. Mr. Lankau is currently a principal of Lankau Consulting LLC. He was previously Executive Chairman of the Board for Nautilus Neurosciences, Inc., Chairman & CEO of Logical Therapeutics, Inc. and President & CEO of Endo Pharmaceuticals Inc. Prior to Endo Pharmaceuticals Inc., he was VP, Sales and Marketing for Alpharma, Inc. He began his pharmaceutical career with Rhone-Poulenc Rorer, Inc. (now Sanofi). Mr. Lankau currently serves on the Board of Directors of ANI Pharmaceuticals, Inc. and Phosphagenics Limited and also on the Board of Advisors of Orchard Venture Partners, a life sciences venture capital firm.

Peter Mugyenyi

Dr. Peter Mugyenyi serves as Independent Director of the Cipla Limited. He is the Director and Co-founder of Joint Clinical Research Centre based in Kampala. He is highly regarded globally for his leadership in helping Africa battle its mounting AIDS epidemic. A pediatrician by training, Dr. Peter Mugyenyi is recognized as one of the worlds’ foremost specialists and researchers in the field of HIV/ AIDS.

Ashok Sinha

Mr. Ashok Sinha serves as Independent Director of Cipla Limited. Mr. Ashok Sinha is an Electrical Engineer from Indian Institute of Technology, Kanpur and Post Graduate Diploma in Management from Indian Institute of Management, Bangalore with specialization in Finance. He is recipient of Distinguished Alumnus Award from NT Kanpur as well as from IIM Bangalore. Mr. Ashok Sinha spent 33 years in Bharat Petroleum Corporation Limited (BPCL), where he served on the Board of BPCL for 15 years - first as Director (Finance) for 10 years and then as its Chairman and Managing Director for 5 years.

Ireena Vittal

Ms. Ireena Vittal serves as Additional Independent Director of the company. Ms. Vittal, a former partner with McKinsey & Company, is an MBA from Indian Institute of Management, Kolkata. She has over two decades of experience in management consulting and is recognised as a thought leader for consumer-facing companies in emerging markets. Prior to joining McKinsey, Ms. Vittal worked with Nestle and MaxTouch (now Vodafone). She has also served government and public institutions to design and implement solutions core to India’s development, such as inclusive urban development and sustainable rural growth

Naveen Bansal

Basic Compensation

Name Fiscal Year Total

Yusuf Hamied

20,200,000

Umang Vohra

136,600,000

Samina Vaziralli

39,200,000

M. Hamied

20,900,000

Kedar Upadhye

--

Rajendra Chopra

--

Adil Zainulbhai

4,200,000

S. Radhakrishnan

20,600,000

Naina Kidwai

4,300,000

Punita Lal

3,800,000

Peter Lankau

1,100,000

Peter Mugyenyi

4,200,000

Ashok Sinha

5,100,000

Ireena Vittal

1,400,000

Naveen Bansal

--
As Of  31 Mar 2017